These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 7522429)
1. Novel mutation (V75T) in human immunodeficiency virus type 1 reverse transcriptase confers resistance to 2',3'-didehydro-2',3'-dideoxythymidine in cell culture. Lacey SF; Larder BA Antimicrob Agents Chemother; 1994 Jun; 38(6):1428-32. PubMed ID: 7522429 [TBL] [Abstract][Full Text] [Related]
2. Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase. Tisdale M; Kemp SD; Parry NR; Larder BA Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5653-6. PubMed ID: 7685907 [TBL] [Abstract][Full Text] [Related]
3. Natural occurrence of drug resistance mutations in the reverse transcriptase of human immunodeficiency virus type 1 isolates. Nájera I; Richman DD; Olivares I; Rojas JM; Peinado MA; Perucho M; Nájera R; López-Galíndez C AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1479-88. PubMed ID: 7534096 [TBL] [Abstract][Full Text] [Related]
4. The valine-to-threonine 75 substitution in human immunodeficiency virus type 1 reverse transcriptase and its relation with stavudine resistance. Selmi B; Boretto J; Navarro JM; Sire J; Longhi S; Guerreiro C; Mulard L; Sarfati S; Canard B J Biol Chem; 2001 Apr; 276(17):13965-74. PubMed ID: 11134027 [TBL] [Abstract][Full Text] [Related]
5. Novel mutation in the human immunodeficiency virus type 1 reverse transcriptase gene that encodes cross-resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine. Gu Z; Gao Q; Li X; Parniak MA; Wainberg MA J Virol; 1992 Dec; 66(12):7128-35. PubMed ID: 1279198 [TBL] [Abstract][Full Text] [Related]
6. The M184V mutation in HIV-1 reverse transcriptase (RT) conferring lamivudine resistance does not result in broad cross-resistance to nucleoside analogue RT inhibitors. Miller V; Stürmer M; Staszewski S; Gröschel B; Hertogs K; de Béthune MP; Pauwels R; Harrigan PR; Bloor S; Kemp SD; Larder BA AIDS; 1998 May; 12(7):705-12. PubMed ID: 9619801 [TBL] [Abstract][Full Text] [Related]
7. Identification of a mutation at codon 65 in the IKKK motif of reverse transcriptase that encodes human immunodeficiency virus resistance to 2',3'-dideoxycytidine and 2',3'-dideoxy-3'-thiacytidine. Gu Z; Gao Q; Fang H; Salomon H; Parniak MA; Goldberg E; Cameron J; Wainberg MA Antimicrob Agents Chemother; 1994 Feb; 38(2):275-81. PubMed ID: 7514855 [TBL] [Abstract][Full Text] [Related]
8. Metabolism of 2',3'-dideoxy-2',3'-didehydro-beta-L(-)-5-fluorocytidine and its activity in combination with clinically approved anti-human immunodeficiency virus beta-D(+) nucleoside analogs in vitro. Dutschman GE; Bridges EG; Liu SH; Gullen E; Guo X; Kukhanova M; Cheng YC Antimicrob Agents Chemother; 1998 Jul; 42(7):1799-804. PubMed ID: 9661024 [TBL] [Abstract][Full Text] [Related]
9. Biochemical mechanism of human immunodeficiency virus type 1 reverse transcriptase resistance to stavudine. Lennerstrand J; Stammers DK; Larder BA Antimicrob Agents Chemother; 2001 Jul; 45(7):2144-6. PubMed ID: 11408240 [TBL] [Abstract][Full Text] [Related]
15. The base component of 3'-azido-2',3'-dideoxynucleosides influences resistance mutations selected in HIV-1 reverse transcriptase. Meteer JD; Koontz D; Asif G; Zhang HW; Detorio M; Solomon S; Coats SJ; Sluis-Cremer N; Schinazi RF; Mellors JW Antimicrob Agents Chemother; 2011 Aug; 55(8):3758-64. PubMed ID: 21646480 [TBL] [Abstract][Full Text] [Related]
16. In vitro study of resistance-associated genotypic mutations to nucleoside analogs. Gashnikova N; Plyasunova O; Kiseleva Y; Fedyuk N; Pokrovsky A Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):991-4. PubMed ID: 14565328 [TBL] [Abstract][Full Text] [Related]
17. High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase. Boucher CA; Cammack N; Schipper P; Schuurman R; Rouse P; Wainberg MA; Cameron JM Antimicrob Agents Chemother; 1993 Oct; 37(10):2231-4. PubMed ID: 7504909 [TBL] [Abstract][Full Text] [Related]
18. Significance of amino acid variation at human immunodeficiency virus type 1 reverse transcriptase residue 210 for zidovudine susceptibility. Harrigan PR; Kinghorn I; Bloor S; Kemp SD; Nájera I; Kohli A; Larder BA J Virol; 1996 Sep; 70(9):5930-4. PubMed ID: 8709214 [TBL] [Abstract][Full Text] [Related]